Two years ago, in 2023, it came as a shock for fans to learn that veteran actress Sharmila Tagore was battling cancer. She was diagnosed with lung cancer, but at stage zero. Recently, her daughter Soha Ali Khan opened up about the experience of her mother being diagnosed early on and how it helped her in treatment and recovery.

In an interaction with Nayandeep Rakshit, she said, "With my mother, she was one of the very few people to be diagnosed with lung cancer at stage zero, and no chemotherapy, nothing. It was cut out of her and she is, touchwood, fine."

The first time the conversation about this was made publicly was during Sharmila's appearance on Koffee with Karan. Host Karan Johar had said, "I would offered Sharmila ji the part played by Shabana ji. She was my very first choice. But because of health reasons at that time, she couldn't say yes." To this, Sharmila responded, "After my cancer...they didn't want me to take that risk."

What Is Stage Zero Lung Cancer?

As per the American Lung Association, Stage Zero is an early-stage lung cancer that is only in the top lining of the lung or bronchus and has not yet spread.

Why Is Staging So Important?

The American Lung Association notes that once your specific type of lung cancer has been identified, the next crucial step in the journey from diagnosis to treatment is staging. This process determines how far the cancer has spread and helps your care team design the most effective treatment plan for you.

To assign a cancer stage, doctors use a combination of imaging tests—such as CT scans and PET scans—and tissue tests like biopsies. These provide a comprehensive view of the cancer’s location and extent.

Staging does more than guide treatment—it also offers insight into your overall prognosis, or likely course of the disease. By looking at data from other patients with the same type and stage of lung cancer, doctors can estimate outcomes. However, it’s important to remember that each case is unique, and no doctor can predict exactly how your cancer will respond to treatment or determine your life expectancy with certainty.

The staging process can vary depending on the individual case. Generally, it starts before treatment begins, based on the results of imaging and biopsy tests. This is called the clinical stage.

For some patients, doctors recommend pre-treatment intranodal staging—also known as invasive nodal staging or intrathoracic staging. This involves examining the lymph nodes in the chest to see if cancer has spread there. Understanding this early can be especially important if the cancer hasn’t yet reached other organs, as it helps doctors determine the full extent of the disease and tailor the treatment accordingly.

Pre-treatment intranodal staging is best done before therapy begins and can sometimes alter the clinical stage based on more detailed information. Two procedures commonly used for this are:

EBUS-TBNA (Endobronchial Ultrasound with Transbronchial Needle Aspiration): A minimally invasive test that uses a bronchoscope and a needle to collect tissue or fluid samples from chest lymph nodes.

Mediastinoscopy: A surgical procedure that allows doctors to examine and take samples from the mediastinum—the space behind the breastbone between the lungs.

If a patient undergoes surgery as their first treatment, doctors may assign a pathological stage afterward. This combines the clinical stage with findings from the surgery itself, often providing a more accurate picture of the disease and informing future treatment steps.

If the cancer returns after treatment, it will be restaged, often using the same types of tests that were done during the initial diagnosis.

What Determines Lung Cancer Stage?

Lung cancer staging is based on three main criteria, commonly referred to as the TNM system:

T (Tumor): Size of the tumor and its exact location in the lung.

N (Nodes): Whether the cancer has spread to nearby lymph nodes, especially in the chest.

M (Metastasis): Whether the cancer has spread to other organs in the body.

Each of these components is assigned a value, which is then used to determine the overall stage of the cancer. This system helps guide treatment decisions and gives patients and caregivers a better understanding of the disease.

Smell is a sense that helps us navigate, feel, and in fact remember things. Thanks or not, but Covid-19 also helped us know its importance, when many people lost the sense of their smell, as one of the major COVID-19 symptom. But, that is not just it, in a podcast posted on Instagram Dr Sanjay Bhojraj, board-certified interventional cardiologist talked to Dr Michael Leon, PhD Professor Emeritus of Neurobiology and Behavior at the Charlie Dunlop School of Biological Sciences on surprising link between smell and overall well-being.

Can Smell Predict How Long Will You Live?

“By the time you reach middle age, your sense of smell can actually predict all-cause mortality,” says Dr Leon. “That means whether you live or die, for any reason, can be accurately reflected in your ability to detect odors.”

The expert says that out olfactory system bears a direct impact to the brain's memory and emotional centers. “It has a great deal of impact when you lose it. And also when you amplify it. When you smell a pleasant odor, it activates the cerebellum and increases sniffing. For example, when you smell a rose, you naturally take a deep sniff.”

How Does Smell Impact Your Brain?

When you encounter a bad or disgusting odor, your body reflexively stops respiration. You instinctively avoid breathing it in,” Dr Leon says.

The expert said it is these subtle responses that influence one's memories, emotions, and overall brain function. “The olfactory system is just much more powerful than most people realize,” he says.

Can Body Odor Also Reveal Things About Your Health?

This link between smell and health became famous when Joy Milne, a retired Scottish nurse, claimed she could detect Parkinson’s disease by scent alone. Years before her husband’s diagnosis, she noticed a distinct musky odor on him. When she later met others with Parkinson’s, they all carried the same smell. Curious scientists put her to the test — and she correctly identified patients just by sniffing their shirts, even predicting one man’s diagnosis a year before doctors confirmed it.

Her unique ability led researchers like Professor Perdita Barran at the University of Manchester to discover that people with Parkinson’s excrete specific lipid-like molecules through their skin. These include hippuric acid and octadecanal, which may form the disease’s distinct odor. Barran’s team is now developing a simple skin-swab test that could help doctors detect Parkinson’s much earlier.

Different diseases create different odors. For example, a fruity or “rotten apple” smell can indicate uncontrolled diabetes, caused by a build-up of ketones. A fishy or ammonia-like scent might suggest kidney problems, while a musty smell could point to liver disease. Even infections leave olfactory traces — cholera, tuberculosis, and C. difficile each produce distinct, unpleasant aromas.

Did you also wake up with a mild cold? A sneeze, blocked nose and a sore throat. It is worse because you had just shaken off the miserable cold and your energy was finally coming back and then now again you are sneezing. So, now the question is, could you really get the same cold twice, or is it just your bad luck?

As per the National Health Service, UK (NHS), adults could get an average of 2 to 4 colds a year. The NHS, UK notes that the viruses behind them behave in a complicated way. This is because some mutate quickly, and some stay in your system. This is why your body's ability to fight them off can differ depending on how well does your immune respond.

Catching The Same Cold, Twice

Conventionally, it is believed that once you have a virus, your body recognizes it and does not let you catch the same virus again. However, this is not the case, always.

Professor Brain Ferguson, who is the professor of viral immunity at the University of Cambridge told Yahoo UK, that it is possible to catch cold twice. This is due to the levels of antibodies that we have in our system.

Ferguson says, "It depends on the quality of the antibodies that your body generates when you get infected the first time. Sometimes your body might make really good ones, and that will stop you being reinfected with the same virus later. But another person might not, and they can catch the same virus, exactly the same one, again later."

The expert further added, "It is also down to the actual molecules, and the constituents of the virus, like proteins and things you make antibodies against. The longer they exist in your body, the better the antibody response tends to be."

This means that the cold can stay in your system, and the longer it stays the better your immune system will be prepared to build up a stronger defense.

Reinfection Time: How Long Does It Take?

If you had two colds very close together, you may not have had enough time to build immune response the first time. Ferguson says, "Reinfection can be very fast."

"It can be as soon as a couple of weeks if the antibody response is very weak... You might pick up a virus and get a few minor symptoms, but fight it off really quickly. In that case, you get much weaker antibodies that fight the virus, which means the same virus appears in your system again very quickly."

This means your body only has a "fleeting encounter" with the virus and thus it won't remember it well enough to protect you the next time. However, a more severe cold may trigger a stronger immune response, which can work as a longer-lasting protection.

Why Some People Catch More Often?

This has something to do with genetics. This is because of their immune system, how good it works against different infections. As Ferguson says, "Some people are just naturally better or worse at fighting off viruses or bacteria due to their genetic makeup."

While it is believed that multivitamins and supplements can help "boost" immunity, Ferguson says that the evidence is mixed.

There’s not a great evidence base for [vitamins] for repeat infections," he says. However, Ferguson adds there is evidence that people who spend more time outside and get more vitamin D tend to have a slightly better-functioning immune system.

"I wouldn't use the word hide," said Dr Sue Goldie to NPR, she is a professor at the Harvard TH Chan School of Public Health, who has finally told the world after four years about her Parkinson's.

She learned about her diagnosis in 2021. She told NPR, "I think I was really trying to give myself room and time to fall apart, to panic, to think about what it meant for me.” For Goldie, silence wasn’t secrecy, it was self-preservation.

She revealed she needed space to understand to first accept that it is happening with her, and secondly to understand how to live with a condition that would alter her movements, her voice, and even her sensing. So she calls the 4-year-gap of not telling anyone as a "process of figuring out how I could be OK."

Parkinson's Disease: How Does It Start?

We often read about Parkinson's disease, what is it, and what it does to someone. However, what we do not talk a lot about is how it starts. We don't talk about the subtle signals one's body sends.

Goldie says it started with a tremor. It was so slight, that it was almost invisible. Then, a running coach mentioned her off cadence. The New York Times (NYT) reports that a trainer noticed her left arm did not lift properly in the pool. Eventually, afterwards, her fingers began twitching. Goldie, then was 50.

She was also at the height of her academic career and was newly obsessed with triathlons. She was in fact, training for Ironman races, reported NYT.

When tests confirmed Parkinson’s, a degenerative neurological disease that affects movement and coordination, her first reaction was disbelief. Then fear. Would her students notice? Would colleagues see her differently?

The diagnosis left her confronting an identity crisis. At what point, she wondered, does a disease become who you are?

Sue With Parkinson's, Who Lived Two Lives

Goldie began to divide her world. At Harvard, she was the confident professor and global health leader, still producing intricate teaching materials and mentoring students. In triathlons, she was freer, surrounded by people who saw her as an athlete, not a patient.

But the effort to maintain that balance came at a cost. As reported by NYT, early mornings were the hardest: walking unsteadily to the bathroom before medication took effect, hiding tremors from colleagues, managing the dopamine pills that controlled her symptoms. “You have no idea how hard it is to trick you into thinking I’m OK,” she later said.

Eventually, she could no longer keep it private. “Starting today, I am Sue with Parkinson’s,” she decided. Most of the people in her professional life would learn about it through her story.

The Camera For Healing

When Goldie's hand tremors made writing impossible, she began to record thousands of video diaries. They were often short, unfiltered glimpses of her daily struggle, which were filmed in her office, car, or home. Sometimes, calm, sometimes in tears.

Her videos began with a "Hello Sue", talking to her future self. In one video as posted by the NYT from 2023, she confessed, “I’m trying hard to do all this stuff that will help, but I’m not feeling OK... I just need to not be alone with it.”

Goldie refused to stop training. Her research had shown that exercise helps manage Parkinson’s symptoms. So, she doubled down, calling herself “an N of 1” — a one-person experiment. She adapted creatively: pink tape on her hands to guide her swim strokes, modified gear on her bike so she wouldn’t lose balance.

In 2022, she completed the Lake Placid Ironman, a 140.6-mile challenge. She crossed the finish line after collapsing, crying, and reapplying lipstick. Her small team called her S.F.G., with the middle initial standing for an unprintable word that captured her spirit.

As her symptoms progressed, Goldie’s fears shifted from physical decline to the erosion of identity. Parkinson’s, she realized, isn’t just about tremors; it’s about dignity, perception, and the quiet grief of being misunderstood.

She worried about whispers at Harvard, about whether others would still see her as capable. When she finally told university leaders, she felt both vulnerable and relieved.

Still, her mission remained unchanged. “I can’t change this,” she told The New York Times in 2024. “So what happens when I get worse?”

She continued teaching, designing, and mentoring. Her hands might tremble, but her mind stayed sharp. “I want to get things done while I’m still the best me,” she said.